Primary Site >> Liver Cancer

Gene >> BUB1

Journal: Int J Cancer. 2001 Jul 20;95(4):223-7.
Title: Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer.
Author: Hernando, E|Orlow, I|Liberal, V|Nohales, G|Benezra, R|Cordon-Cardo, C
PMID: 11400114
Journal: Cancer. 2002 Apr 1;94(7):2047-54.
Title: Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma.
Author: Saeki, Ayuko|Tamura, Shinji|Ito, Nobuyuki|Kiso, Shinichi|Matsuda, Yasuo|Yabuuchi, Iwao|Kawata, Sumio|Matsuzawa, Yuji
PMID: 11932908
Journal: BMC Med Genomics. 2008 Oct 10;1:49.
Title: The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines.
Author: Regenbrecht, Christian Ra|Jung, Marc|Lehrach, Hans|Adjaye, James
PMID: 18847459
Journal: Pathol Res Pract. 2017 Apr;213(4):316-321.
Title: Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Author: Yan, Hongxian|Li, Zhaohui|Shen, Quan|Wang, Qian|Tian, Jianguo|Jiang, Qingfeng|Gao, Linbo
PMID: 28238542
Journal: J Cancer. 2017 May 12;8(8):1378-1394.
Title: Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability.
Author: Hsu, Chao-Wen|Chen, Yu-Chia|Su, Hsing-Hao|Huang, Guan-Jin|Shu, Chih-Wen|Wu, Tony Tong-Lin|Pan, Hung-Wei
PMID: 28638452
Journal: Pharmacology. 2017;100(5-6):269-282.
Title: MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells.
Author: Xu, Bin|Xu, Tangpeng|Liu, Huali|Min, Qian|Wang, Shidong|Song, Qibin
PMID: 28810242
Journal: Oncol Rep. 2017 Nov;38(5):2607-2618.
Title: Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Author: Li, Lin|Lei, Qingsong|Zhang, Shujun|Kong, Lingna|Qin, Bo
PMID: 28901457
Journal: Cancer Genet. 2017 Oct;216-217:37-51.
Title: Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Author: Agarwal, Rahul|Narayan, Jitendra|Bhattacharyya, Amitava|Saraswat, Mayank|Tomar, Anil Kumar
PMID: 29025594
Journal: Onco Targets Ther. 2018 Mar 23;11:1683-1695.
Title: Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer.
Author: Yuan, Wen|Xie, Songping|Wang, Meng|Pan, Shan|Huang, Xiaoxing|Xiong, Meng|Xiao, Rui-Jing|Xiong, Jie|Zhang, Qiu-Ping|Shao, Liang
PMID: 29615843
Journal: Med Sci Monit. 2018 May 5;24:2786-2808.
Title: Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Author: Wen, Dong-Yue|Lin, Peng|Pang, Yu-Yan|Chen, Gang|He, Yun|Dang, Yi-Wu|Yang, Hong
PMID: 29728556
Journal: Cancer Biomark. 2018;22(3):511-521.
Title: Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
Author: Zhang, Liang|Huang, Yi|Ling, Junjun|Zhuo, Wenlei|Yu, Zhen|Shao, Mengmeng|Luo, Yunbo|Zhu, Yi
PMID: 29843214
Journal: Mol Med Rep. 2018 Sep 19.
Title: Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B viruspositive cirrhosis.
Author: Chen, Qi-Feng|Xia, Jin-Guo|Li, Wang|Shen, Lu-Jun|Huang, Tao|Wu, Peihong
PMID: 30272310